| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| IBT6A hydrochloride |
3-(4-苯氧基苯基)-1-(3R)-3-哌啶基-1H-吡唑并[3,4-D]嘧啶-4-胺鹽酸鹽(1:1) |
1553977-42-6 |
詳細(xì)
|
| Sofiniclin |
BNC375 |
1557240-80-8 |
詳細(xì)
|
| Avitinib |
艾維替尼 |
1557267-42-1 |
詳細(xì)
|
| LE135 |
LE 135 |
155877-83-1 |
詳細(xì)
|
| KG5 |
納替尼-D8 |
1562993-37-6 |
詳細(xì)
|
| PARP1-IN-11 |
G244-LM |
1563007-08-8 |
詳細(xì)
|
| HTH-01-091 TFA |
MTI-31 |
1567915-38-1 |
詳細(xì)
|
| DBIBB |
DBIBB |
1569309-92-7 |
詳細(xì)
|
| TAK1-IN-4 |
化合物HS220 |
1570374-32-1 |
詳細(xì)
|
| Tenofovir amibufenamide |
艾米替諾福韋 |
1571076-26-0 |
詳細(xì)
|
| MONNA |
2-(4-甲氧基萘-2-基氨基)-5-硝基苯甲酸 |
1572936-83-4 |
詳細(xì)
|
| PU139 |
PU139 |
158093-65-3 |
詳細(xì)
|
| IT-901 |
IT-901 |
1584121-99-2 |
詳細(xì)
|
| PSI |
Z-異亮氨酰-叔丁基谷氨酰-丙氨酸-亮氨酸縮醛 |
158442-41-2 |
詳細(xì)
|
| Tankyrase-IN-2 |
TANKYRASE-IN-2 |
1588870-36-3 |
詳細(xì)
|
| BRD0209 |
化合物 T26894 |
1597439-87-6 |
詳細(xì)
|
| Rodatristat |
RODATRISTAT |
1673568-73-4 |
詳細(xì)
|
| Dimethoxycurcumin |
DIMETHOXYCURCUMIN |
160096-59-3 |
詳細(xì)
|
| bio-THZ1 |
bio-THZ1 |
1604811-14-4 |
詳細(xì)
|
| DY268 |
DY 268 |
1609564-75-1 |
詳細(xì)
|
| Glicoricone |
甘草瑞酮 |
161099-37-2 |
詳細(xì)
|
| Tuvusertib |
ATR INHIBITOR 1 |
1613200-51-3 |
詳細(xì)
|
| EIDD-2749 |
4'-C-Fluoro-uridine |
1613589-24-4 |
詳細(xì)
|
| Linsidomine hydrochloride |
5-氨基-3-(4-嗎啉基)-1,2,3-惡二唑鹽酸鹽 |
16142-27-1 |
詳細(xì)
|
| PF-06372865 |
PF-06372865 |
1614245-70-3 |
詳細(xì)
|
| Netoglitazone |
MCC-555 |
161600-01-7 |
詳細(xì)
|
| Camlipixant |
BLU-5937 |
1621164-74-6 |
詳細(xì)
|
| LY3177833 monhydrate |
化合物L(fēng)Y3143921 HYDRATE |
1627696-53-0 |
詳細(xì)
|
| SGK1-IN-4 |
化合物SGK1-IN-4 |
1628048-93-0 |
詳細(xì)
|
| IEM-1754 |
IEM 1754 DIHYDROBROMIDE |
162831-31-4 |
詳細(xì)
|
| GNE-131 |
CS-2887 |
1629063-81-5 |
詳細(xì)
|
| Oxymatrine |
SRI011381 |
1629138-41-5 |
詳細(xì)
|
| CDK8-IN-1 |
CDK8-IN-1 |
1629633-48-2 |
詳細(xì)
|
| (R)-DNMDP |
(R)-DNMDP |
1630760-60-9 |
詳細(xì)
|
| KLH45 |
KLH45 |
1632236-44-2 |
詳細(xì)
|
| 680C91 |
680C91 |
163239-22-3 |
詳細(xì)
|
| KA2507 |
Benzamide, 4-[(di-2-pyrazinylamino)methyl]-N-hydroxy- |
1636894-46-6 |
詳細(xì)
|
| GS-626510 |
GS-626510 |
1637770-13-8 |
詳細(xì)
|
| ABR-238901 |
化合物ABR-238901 |
1638200-22-2 |
詳細(xì)
|
| Nigericin |
BAX ACTIVATOR-1 |
1638526-94-9 |
詳細(xì)
|
| JC124 |
Benzamide, 5-chloro-2-methoxy-N-[2-[4-[(methylamino)sulfonyl]phenyl]ethyl]- |
1638611-48-9 |
詳細(xì)
|
| Salvianolic acid Y |
Salvianolic acid Y |
1638738-76-7 |
詳細(xì)
|
| HSK0935 |
HSK0935 |
1638851-44-1 |
詳細(xì)
|
| ARN14974 |
ARN14974 |
1644158-57-5 |
詳細(xì)
|
| Iptacopan hydrochloride |
化合物L(fēng)NP023 HYDROCHLORIDE |
1646321-63-2 |
詳細(xì)
|
| FD-IN-1 |
FD-IN-1 |
1646682-14-5 |
詳細(xì)
|
| Epiblastin A |
Epiblastin A |
16470-02-3 |
詳細(xì)
|
| Vomifoliol |
CS-1661 |
1649450-12-3 |
詳細(xì)
|
| GSK121 |
GSK121 (trifluoroacetate salt) |
1652591-80-4 |
詳細(xì)
|
| BRD4 Inhibitor-10 |
BRD4 INHIBITOR-10 |
1660117-38-3 |
詳細(xì)
|
| Rodatristat ethyl |
RODATRISTAT ETHYL |
1673571-51-1 |
詳細(xì)
|
| 6-Chloro-7-deazapurine-β-D-riboside |
6-氯-7-脫氮-9-(Β-D-呋喃核糖基)嘌呤 |
16754-80-6 |
詳細(xì)
|
| FzM1 |
FzM1 |
1680196-54-6 |
詳細(xì)
|
| Venadaparib |
Venadaparib |
1681017-83-3 |
詳細(xì)
|
| Spinosad |
刺糖菌素 |
168316-95-8 |
詳細(xì)
|
| NXP800 |
NPX-809 |
1693734-80-3 |
詳細(xì)
|
| Erastin2 |
4(3H)-Quinazolinone, 2-[[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]methyl]-3-[4-(1-methylethoxy)[1,1'-biphenyl]-3-yl]- |
1695533-44-8 |
詳細(xì)
|
| FGFR4-IN-1 |
CS-2343 |
1708971-72-5 |
詳細(xì)
|
| bpV(phen) trihydrate |
bpV(phen) (potassium hydrate) |
171202-16-7 |
詳細(xì)
|
| (S,S)-TAPI-1 |
TAPI-1 |
171235-71-5 |
詳細(xì)
|
| PB28 dihydrochloride |
化合物 T23122 |
172907-03-8 |
詳細(xì)
|
| Ganoderic acid DM |
靈芝酸DM |
173075-45-1 |
詳細(xì)
|
| TC-E 5003 |
N,N'-[磺?；?4,1-亞苯基)]二(2-氯乙酰胺) |
17328-16-4 |
詳細(xì)
|
| YM-244769 dihydrochloride |
YM-244769二鹽酸鹽 |
1780390-65-9 |
詳細(xì)
|
| RN-1 dihydrochloride |
RN1; RN 1 |
1781835-13-9 |
詳細(xì)
|
| Cudetaxestat |
化合物CUDETAXESTAT |
1782070-21-6 |
詳細(xì)
|
| N-Methyl-DL-aspartic acid |
甲基天冬氨酸 |
17833-53-3 |
詳細(xì)
|
| Nav1.7-IN-3 |
NAV1.7-IN-3 |
1788872-06-9 |
詳細(xì)
|
| Lapatinib ditosylate |
SRS16-86 |
1793052-96-6 |
詳細(xì)
|
| VX-150 |
N-[1,2-二氫-2-氧代-1-[(膦酰氧基)甲基]-4-吡啶基]-2-(4-氟-2-甲基苯氧基)-4-(三氟甲基)苯甲酰胺 |
1793080-72-4 |
詳細(xì)
|
| MG-262 |
Z-Leu-Leu-Leu-B(OH)2 (MG262) |
179324-22-2 |
詳細(xì)
|
| CJ-13,610 |
化合物 T27026 |
179420-17-8 |
詳細(xì)
|
| TD52 |
TD52 |
1798328-24-1 |
詳細(xì)
|
| LSP-249 |
LSP-249 |
1801253-04-2 |
詳細(xì)
|
| Ganoderlactone D |
3Β,7Β,12Β-三羥基-11,15-二羰基-羊毛甾烷-8-烯-24→20內(nèi)酯 |
1801934-15-5 |
詳細(xì)
|
| ONO-8590580 |
CS-2894 |
1802661-73-9 |
詳細(xì)
|
| L-Phenylalanine-13C6 |
L-苯丙氨酸-13C6 |
180268-82-0 |
詳細(xì)
|
| PDE12-IN-3 |
PDE12-IN-3 |
1803357-22-3 |
詳細(xì)
|
| WCK-4234 |
阿維巴坦雜質(zhì)46 |
1804915-68-1 |
詳細(xì)
|
| SMS1-IN-1 |
SMS1-IN-1 |
1807943-38-9 |
詳細(xì)
|
| Bictegravir sodium |
比卡格韋 |
1807988-02-8 |
詳細(xì)
|
| Conoidin A |
1,4-二氧代-2,3-二溴甲基喹啉 |
18080-67-6 |
詳細(xì)
|
| LP99 |
化合物L(fēng)P99 |
1808951-93-0 |
詳細(xì)
|
| T-3764518 |
T-3764518 |
1809151-56-1 |
詳細(xì)
|
| DTP3 |
DTP3 |
1809784-29-9 |
詳細(xì)
|
| MAP4K4-IN-3 |
MAP4K4-IN-17 |
1811510-58-3 |
詳細(xì)
|
| Bevurogant |
化合物BEVUROGANT |
1817773-66-2 |
詳細(xì)
|
| MPT0B390 |
2-PROPENAMIDE, 3-[2,3-DIHYDRO-1-[(4-METHOXYPHENYL)SULFONYL]-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N-HYDROXY |
1817802-18-8 |
詳細(xì)
|
| 1,2-Dimyristoyl-sn-glycero-3-phosphocholine |
二肉豆蔻酰磷脂酰膽堿（DMPC） |
18194-24-6 |
詳細(xì)
|
| GlyT1 Inhibitor 1 |
GlyT1 Inhibitor 1 |
1820934-93-7 |
詳細(xì)
|
| PythiDC |
化合物PYTHIDC |
1821370-71-1 |
詳細(xì)
|
| AZ9482 |
AZ 9482;AZ-9482 |
1825345-33-2 |
詳細(xì)
|
| Ubiquitination-IN-1 |
UBIQUITINATION-IN-1 |
1819330-15-8 |
詳細(xì)
|
| LEM-14 |
化合物 T9006 |
1814881-70-3 |
詳細(xì)
|
| (Rac)-EC5026 |
化合物 UREA, N-[3-FLUORO-4-(TRIFLUOROMETHOXY)PHENYL]-N'-[1-(2-METHYL-1-OXOBUTYL)-4-PIPERIDINYL]- |
1809885-55-9 |
詳細(xì)
|
| MMP13-IN-2 |
ND-336 |
1807453-83-3 |
詳細(xì)
|
| ICCB-19 hydrochloride |
N-cycloheptyl-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)acetamide hydrochloride |
1803605-68-6 |
詳細(xì)
|
| GX-201 |
GX 201 |
1788071-27-1 |
詳細(xì)
|
| Ro60-0175 |
Ro 60-0175 |
169675-08-5 |
詳細(xì)
|
| BMS453 |
BMS453 |
166977-43-1 |
詳細(xì)
|